Dr. Swamy Venuturupalli, MD, FACR Los Angeles, CA - 90048

Dr. Swamy Venuturupalli, MD, FACR is categorized under Rheumatologists in Los Angeles, CA and active since 2002.

Dr. Swamy Venuturupalli, MD, FACR was established in 2002, and today employs 1 to 4, earning Unknown per year. This is a Rheumatologists business, which does work in the B2C market, and is classified as a Rheumatologists, under code number by the NAICS.

If you are seeking more information, feel free to contact Swamy Venuturupalli at the company’s single location by writing to 8737 Beverly Boulevard, Suite 302, Los Angeles, California CA 90048 or by phoning (310) 659-9959. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dr. Swamy Venuturupalli, MD, FACR
Contact Person: Swamy Venuturupalli
Address: 8737 Beverly Boulevard, Suite 302, Los Angeles, California 90048
Phone Number: (310) 659-9959
Website Address: drswamy.com
Annual Revenue (USD): Unknown
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Rheumatologists
Share This Business:

Dr. Swamy Venuturupalli, MD, FACR was started in 2002 to provide professional Rheumatologists under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Swamy Venuturupalli for inquiries that concern Dr. Swamy Venuturupalli, MD, FACR by calling the company number (310) 659-9959, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr. Swamy Venuturupalli, MD, FACR can be found at the coordinates 34.0770637,-118.3817753 as well as the street address 8737 Beverly Boulevard, Suite 302 in Los Angeles, California 90048.

For its online presence, you may visit Dr. Swamy Venuturupalli, MD, FACR’s website at drswamy.com and engage with its social media outlets through on Twitter and on Facebook.